2,3-oxidosqualene-lanosterol cyclase inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 15, 2005
Grant Date -
Jun 6, 2002
app pub date -
Aug 27, 2001
filing date -
Sep 8, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to piperidine derivatives useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully